The contract research organization will launch an expanded ISO 18562 gas pathway testing program and ISO 10993-18 particulate ...
Medical Device Network on MSN
NAMSA acquires Labcorp’s medical device testing assets
The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.
Eurofins Medical Device Services North America, part of a global network of over 20 medical device testing laboratories and a leading medical device solutions partner, recently launcheda GMPPFAS ...
NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has ...
Good Laboratory Practice certification expands company's ability to support medical device manufacturers in meeting the complex demands of international regulatory frameworks "Our customers are ...
STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the availability of its robust In Vitro Micronucleus Test service to meet the ...
Namsa, which is backed by Archimed, has acquired Labcorp’s US-based early development medical testing business. No financial ...
TOLEDO, Ohio, March 3, 2025 /PRNewswire/ -- NAMSA, a leading US based MedTech testing, clinical and regulatory consulting firm, announced that it finalized its acquisition of WuXi AppTec's US medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback